Alibaba will sell a number of its Tmall Pharmacy units to Alibaba Health Information Technology

By Catherine Sturman
Chinese juggernaut Alibaba Group Holding Ltd has announced its decision to sell a number of its online pharmacy business units in a new $1.35bn deal. Th...

Chinese juggernaut Alibaba Group Holding Ltd has announced its decision to sell a number of its online pharmacy business units in a new $1.35bn deal. Through the sale, Alibaba will gain up to HK$10.6bn in newly issued shares of Hong-Kong listed Alibaba Health, Alizila has reported.

Units which will move to the digital health subsidiary Alibaba Health from the company’s B2C platform Tmall Pharmacy will consist of a multitude of healthcare products and services, as well as medical devices, making this division its core healthcare arm.

“Healthcare is a strategically important area for Alibaba Group with strong growth potential. This transaction is a logical evolution for the continued development of Alibaba Health into our healthcare flagship platform,” explained Alibaba Group CEO Daniel Zhang.

“Alibaba Health’s knowledge and network, in combination with Alibaba Group’s consumer insights and technology, will enable us to create the best healthcare ecosystem in China.”

See also

With rivals such as WeDoctor and Ping An Healthcare dominating recent headlines, it was only a matter of time before Alibaba followed suit to gain an edge over such a competitive market, cater towards ongoing consumer trends and support vendors to provide exceptional patient care across the industry.

“Alibaba Group has been very supportive to the development of Alibaba Health as the group’s flagship platform in the healthcare sector,” noted Alibaba Health CEO Leo Shen.

“The transaction strengthens Alibaba Health’s market leadership and recognises our contribution to the healthcare industry in China. It will allow us to expand our business by adding more complementary categories and enabling us to have deeper engagement with more participants.”

Upon completion, Alibaba will see its equity ownership and voting interest in Alibaba Health rise to 56.2% and 67.5% respectively.

Share

Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma